A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis

@article{Bertholet2010ADT,
  title={A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis},
  author={S. Bertholet and Gregory C. Ireton and D. Ordway and H. Windish and Samuel O. Pine and Maria Kahn and Tony Phan and I. Orme and T. Vedvick and S. Baldwin and R. Coler and S. Reed},
  journal={Science Translational Medicine},
  year={2010},
  volume={2},
  pages={53ra74 - 53ra74}
}
  • S. Bertholet, Gregory C. Ireton, +9 authors S. Reed
  • Published 2010
  • Medicine
  • Science Translational Medicine
  • A vaccine with a four-protein fusion peptide from Mycobacterium tuberculosis effectively boosts the current childhood TB vaccine and protects against drug-resistant TB. A Superior Shot for Tuberculosis Going to the doctor for routine “shots” is a dreaded childhood right of passage. The freedom from serious diseases—polio, smallpox, and diphtheria—clearly compensates for the pain. But one shot given in many countries (but not the United States)—bacillus Calmette-Guérin (BCG), a vaccine against… CONTINUE READING
    234 Citations
    Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice
    • 6
    • Highly Influenced
    • PDF
    Targeting innate immunity for tuberculosis vaccination.
    • 20
    • Highly Influenced
    • PDF
    Novel vaccination strategies against tuberculosis.
    • 112
    • Highly Influenced
    • PDF
    Vaccine against tuberculosis: what’s new?
    • 51
    • Highly Influenced
    Exacting Edward Jenner’s revenge: The quest for a new tuberculosis vaccine
    • 2
    • Highly Influenced
    • PDF
    A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation
    • 12
    • Highly Influenced
    Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination
    • 66
    • Highly Influenced
    • PDF
    Tuberculosis vaccine development at a divide
    • S. Kaufmann
    • Medicine
    • Current opinion in pulmonary medicine
    • 2014
    • 33
    • Highly Influenced
    • PDF

    References

    SHOWING 1-10 OF 39 REFERENCES
    Novel prophylactic and therapeutic vaccine against tuberculosis.
    • 42
    • Highly Influential
    Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis1
    • 128
    • PDF
    A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis
    • Sci. Transl. Med
    • 2010
    Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen.
    • 67
    Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations.
    • 98
    Scien adjuvanted with IC 31 promotes strong and long - lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
    • Vaccine
    • 2010
    Zheng for their technical expertise; and L. Kunz for guinea pig tissue histology
    • Submitted 22 March 2010 Accepted
    • 2010
    Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
    • 145
    • PDF